journal article Open Access Dec 01, 2016

Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (PFAAs) in occupational workers in China

View at Publisher Save 10.1038/srep38039
Abstract
AbstractPaired serum and urine samples were collected from workers in a fluorochemical plant from 2008 to 2012 (n = 302) to investigate the level, temporal trends, and half-lives of PFAAs in workers of a fluorochemical plant. High levels of perfluorohexane sulfonate (PFHxS), perfluorooctanoic acid (PFOA), and perfluorooctanesulfonate (PFOS) were detected in serum with median concentrations of 764, 427, and 1725 ng mL−1, respectively. The half-lives of PFAAs in workers were estimated by daily clearance rates and annual decline rates of PFAAs in serum by a first-order model. The geometric mean and median value for PFHxS, PFOA, and PFOS were 14.7 and 11.7, 4.1 and 4.0, 32.6 and 21.6 years, respectively, by the daily clearance rates, and they were 3.6, 1.7, and 1.9 years estimated by annual decline rates. The half-lives estimated by the limited clearance route information could be considered as the upper limits for PFAAs, however, the huge difference between two estimated approaches indicated that there were other important elimination pathways of PFAAs other than renal clearance in human. The half-lives estimated by annual decline rates in the present study were the shortest values ever reported, and the intrinsic half-lives might even shorter due to the high levels of ongoing exposure to PFAAs.
Topics

No keywords indexed for this article. Browse by subject →

References
48
[1]
Key, B. D., Howell, R. D. & Criddle, C. S. Fluorinated organics in the biosphere. Environ. Sci. Technol. 31, 2445–2454 (1997). 10.1021/es961007c
[2]
Paul, A. G., Jones, K. C. & Sweetman, A. J. A first global production, emission and environmental inventory for perfluorooctane sulfonate. Environ. Sci. Technol. 43, 386–392 (2009). 10.1021/es802216n
[3]
Wang, Y. et al. Distribution of perfluorooctane sulfonate and other perfluorochemicals in the ambient environment around a manufacturing facility in China. Environ. Sci. Technol. 44, 8062–8067 (2010). 10.1021/es101810h
[4]
Shi, Y. L., Pan, Y. Y., Yang, R. Q., Wang, Y. W. & Cai, Y. Q. Occurrence of perfluorinated compounds in fish from Qinghai-Tibetan Plateau. Environ. Int. 36, 46–50 (2010). 10.1016/j.envint.2009.09.005
[5]
Cai, M. H. et al. Occurrence of perfluoroalkyl compounds in surface waters from the North Pacific to the Arctic Ocean. Environ. Sci. Technol. 46, 661–668 (2012). 10.1021/es2026278
[6]
Shoeib, M., Harner, T. & Vlahos, P. Perfluorinated chemicals in the Arctic atmosphere. Environ. Sci. Technol. 40, 7577–7583 (2006). 10.1021/es0618999
[7]
Lopez-Espinosa, M. J. et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ. Sci. Technol. 45, 8160–8166 (2011). 10.1021/es1038694
[8]
Uhl, S. A., James-Todd, T. & Bell, M. L. Association of osteoarthritis with perfluorooctanoate and perfluorooctane sulfonate in NHANES 2003–2008. Enviro. Health Perspect. 121, 447–452 (2013). 10.1289/ehp.1205673
[9]
Bonefeld–Jorgensen, E. C. et al. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: A case control study. Environ. Health-Glob. 10, 88 (2011). 10.1186/1476-069x-10-88
[10]
Dallaire, R., Dewailly, É., Pereg, D., Dery, S. & Ayotte, P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ. Health Perspect. 117, 1380–1386 (2009). 10.1289/ehp.0900633
[11]
Wang, T., Wang, Y. W., Liao, C. Y., Cai, Y. Q. & Jiang, G. B. Perspectives on the inclusion of perfluorooctane sulfonate into the Stockholm Convention on persistent organic pollutants. Environ. Sci. Technol. 43, 5171–5175 (2009). 10.1021/es900464a
[12]
Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003–2011

Emiko Okada, Ikuko Kashino, Hideyuki Matsuura et al.

Environment International 2013 10.1016/j.envint.2013.07.013
[13]
Route, W. T., Key, R. L., Russell, R. E., Lindstrom, A. B. & Strynar, M. J. Spatial and temporal patterns in concentrations of perfluorinated compounds in bald eagle nestlings in the upper midwestern United States. Environ. Sci. Technol. 48, 6653–6660 (2014). 10.1021/es501055d
[14]
Toms, L. M. L. et al. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011. Environ. Int. 71, 74–80 (2014). 10.1016/j.envint.2014.05.019
[15]
Xie, S. W. et al. Industrial source identification and emission estimation of perfluorooctane sulfonate in China. Environ. Int. 52, 1–8 (2013). 10.1016/j.envint.2012.11.004
[16]
Conder, J. M., Hoke, R. A., De Wolf, W., Russell, M. H. & Buck, R. C. Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ. Sci. Technol. 42, 995–1003 (2008). 10.1021/es070895g
[17]
Ng, C. A. & Hungerbuhler, K. Bioaccumulation of perfluorinated alkyl acids, observations and models. Environ. Sci. Technol. 48, 4637–4648 (2014). 10.1021/es404008g
[18]
Salvalaglio, M., Muscionico, I. & Cavallotti, C. Determination of energies and sites of binding of PFOA and PFOS to human serum albumin. J. Phys. Chem. B 114, 14860–14874 (2010). 10.1021/jp106584b
[19]
Liu, J. Y., Li, J. G., Luan, Y., Zhao, Y. F. & Wu, Y. N. Geographical distribution of perfluorinated compounds in human blood from Liaoning Province, China. Environ. Sci. Technol. 43, 4044–4048 (2009). 10.1021/es9002229
[20]
Olsen, G. W., Burris, M. M. & Mandel, J. M. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 45, 260–270 (2003). 10.1097/01.jom.0000052958.59271.10
[21]
Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers

Geary W. Olsen, Jean M. Burris, David J. Ehresman et al.

Environmental Health Perspectives 2007 10.1289/ehp.10009
[22]
Olsen, G. W. et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American red cross adult blood donors, 2000–2006. Environ. Sci. Technol. 42, 4989–4995 (2008). 10.1021/es800071x
[23]
Olsen, G. W. et al. Temporal trends of perfluoroalkyl concentrations in American red cross adult blood donors, 2000–2010. Environ. Sci. Technol. 46, 6330–6338 (2012). 10.1021/es300604p
[24]
Association of Perfluorooctanoic Acid with HDL Cholesterol and Circulating miR-26b and miR-199–3p in Workers of a Fluorochemical Plant and Nearby Residents

Jianshe Wang, Yating Zhang, Wei Zhang et al.

Environmental Science & Technology 2012 10.1021/es300906q
[25]
Yeung, L. W. et al. Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ. Sci. Technol. 40, 715–720 (2006). 10.1021/es052067y
[26]
Zhao, Y. G., Wong, C. K. C. & Wong, M. H. Environmental contamination, human exposure and body loadings of perfluorooctane sulfonate (PFOS), focusing on Asian countries. Chemosphere 89, 355–368 (2012). 10.1016/j.chemosphere.2012.05.043
[27]
Olsen, G. W. et al. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology 256, 65–74 (2009). 10.1016/j.tox.2008.11.008
[28]
Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life

Yifeng Zhang, Sanjay Beesoon, Lingyan Zhu et al.

Environmental Science & Technology 2013 10.1021/es401905e
[29]
Han, X., Nabb, D. L., Russell, M. H., Kennedy, G. L. & Rickard, R. W. Renal elimination of perfluorocarboxylates (PFCAs). Chem. Res. Toxicol. 25, 35–46 (2012). 10.1021/tx200363w
[30]
Harada, K. H. et al. Biliary excretion and cerebrospinal fluid partition of perfluorooctanoate and perfluorooctane sulfonate in humans. Environ. Toxicol. Phar. 24, 134–139 (2007). 10.1016/j.etap.2007.04.003
[31]
Pan, Y. Y., Shi, Y. L. & Cai, Y. Q. Determination of perfluorinated compounds in human blood samples by high performance liquid chromatography-electrospray tandem mass spectrometry. Chinese J. Anal. Chem. 36, 1321–1326 (2008). 10.1016/s1872-2040(08)60072-9
[32]
Ohmori, K., Kudo, N., Katayama, K. & Kawashima, Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184, 135–140 (2003). 10.1016/s0300-483x(02)00573-5
[33]
Thompson, J. et al. Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid. Environ. Int. 36, 390–397 (2010). 10.1016/j.envint.2010.02.008
[34]
WS/T 428-2013. Criteria of weight for adults, Issued by National Health and Family Planning Commission of the People’s Republic of China (2013).
[35]
Fu, J. et al. Elevated levels of perfluoroalkyl acids in family members of occupationally exposed workers, the importance of dust transfer. Sci. Rep. 5 (2015). 10.1038/srep09313
[36]
Andersen, M. E., Clewell, H. J., Tan, Y. M., Butenhoff, J. L. & Olsen, G. W. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - Probing the determinants of long plasma half-lives. Toxicology 227, 56–164 (2006). 10.1016/j.tox.2006.08.004
[37]
Cui, L. et al. Excretion of PFOA and PFOS in male rats during a subchronic exposure. Arch. Environ. Con. Tox. 58, 205–213 (2010). 10.1007/s00244-009-9336-5
[38]
Beesoon, S., Genuis, S. J., Benskin, J. P. & Martin, J. W. Exceptionally high serum concentrations of perfluorohexanesulfonate in a canadian family are linked to home carpet treatment applications. Environ. Sci. Technol. 46, 12960–12967 (2012). 10.1021/es3034654
[39]
Highly Elevated Serum Concentrations of Perfluoroalkyl Substances in Fishery Employees from Tangxun Lake, China

Zhen Zhou, Robin Vestergren, Thanh Wang et al.

Environmental Science & Technology 2014 10.1021/es4057467
[40]
Harada, K. et al. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ. Res. 99, 253−261 (2005). 10.1016/j.envres.2004.12.003
[41]
Wong, F., MacLeod, M., Mueller, J. F. & Cousins, I. T. Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling. Environ. Sci. Technol. 48, 8807–8814 (2014). 10.1021/es500796y
[42]
Bartell, S. M. Bias in half-life estimates using log concentration regression in the presence of background exposures, and potential solutions. J. Expo. Sci. Env. Epid. 22, 299–303 (2012). 10.1038/jes.2012.2
[43]
Russell, M. H., Waterland, R. L. & Wong, F. Calculation of chemical elimination half-life from blood with an ongoing exposure source: The example of perfluorooctanoic acid (PFOA). Chemosphere 129, 210–216 (2015). 10.1016/j.chemosphere.2014.07.061
[44]
Noker, P. E. & Gorman, G. S. A pharmacokinetic study of potassium perfluorooctanesulfonate in the cynomolgus monkey. U.S. EPA docket AR-226-1356. Washington, DC: U.S. Environmental Protection Agency (2003).
[45]
Noker, P. E. & Gorman, G. S. A pharmacokinetic study of potassium perfluorohexanesulfonate in the cynomolgus monkey. U.S. EPA docket AR-226-1361. Washington, DC: U.S. Environmental Protection Agency (2003).
[46]
Benskin, J. P. et al. Disposition of perfluorinated acid isomers in Sprague-dawley rats; Part 1, Single dose. Environ. Toxicol. Chem. 28, 542–554 (2009). 10.1897/08-239.1
[47]
Lupton, S. J., Huwe, J. K., Smith, D. J., Dearfield, K. L. & Johnston, J. J. Absorption and excretion of 14C-perfluorooctanoic acid (PFOA) in Angus Cattle (Bos Taurus). J. Agric. Food Chem. 60, 1128−1134 (2012). 10.1021/jf2042505
[48]
Lupton, S. J., Huwe, J. K., Smith, D. J., Dearfield, K. L. & Johnston, J. J. Distribution and excretion of perfluorooctane sulfonate (PFOS) in beef cattle (Bos taurus). J. Agric. Food Chem. 62, 1167−1173 (2014). 10.1021/jf404355b
Cited By
160
Restricted substances for textiles

Arun Kumar Patra, Siva Rama Kumar Pariti · 2022

Textile Progress